Orchestra BioMed Holdings, Inc.
OBIO
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Revenues | 33.5 | 33.5 | 2.6 | 2.8 | -0.8 | 5.7 | |
| Cost of Revenues | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | |
| Gross Profit | 33.3 | 33.3 | 2.4 | 2.6 | -1.0 | 5.6 | |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 33.8 | 12.9 | 13.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 20.3 | 7.9 | 10.8 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | |
| Total Operating Expenses | 85.1 | 85.1 | 66.7 | 54.1 | 20.8 | 24.3 | |
| Operating Income | -51.8 | -51.8 | -64.3 | -51.5 | -21.8 | -18.8 | |
| Net Income | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Interest Income | 0.2 | 0.0 | 3.4 | 3.8 | 0.0 | 0.3 | |
| Interest Expense | 1.3 | 1.1 | 0.0 | 0.0 | 0.9 | 0.0 | |
| Other Expense | -0.9 | -1.1 | 3.3 | 2.4 | -0.3 | -2.9 | |
| IBT | -52.7 | -53.0 | -61.0 | -49.1 | -23.0 | -21.4 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 2.6 | |
| Net Income | -52.7 | -53.0 | -61.0 | -49.1 | -23.0 | -21.4 | |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.48 | $-0.73 | $-0.68 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.48 | $-0.73 | $-0.68 | |
| Shares Outstanding | 38.4 | 38,392.7 | 36.8 | 33.2 | 31.6 | 31.6 | |
| Diluted Shares Outstanding | 38.4 | 38,392.7 | 36.8 | 33.2 | 31.6 | 31.6 | |
| Current Assets | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Cash And Equivalents | 23.7 | 22.3 | 30.6 | 9.9 | 20.3 | |
| Short Term Investments | 41.5 | 44.6 | 57.0 | 1.0 | 15.4 | |
| Total Cash & ST Investments | 65.2 | 66.8 | 87.6 | 10.9 | 35.8 | |
| Accounts Receivable | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | |
| Inventory | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Other Current Assets | 1.1 | 2.1 | 1.3 | 0.2 | 0.2 | |
| Total Current Assets | 66.5 | 69.2 | 89.1 | 11.3 | 36.3 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.6 | 3.5 | 2.8 | 1.1 | 1.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 2.5 | 2.5 | 2.5 | 0.4 | 0.2 | |
| Other Long-Term Assets | 0.8 | 1.0 | 0.8 | 0.7 | 0.6 | |
| Total Long-Term Assets | 5.9 | 7.0 | 6.1 | 2.2 | 1.8 | |
| Total Assets | 72.4 | 76.2 | 95.2 | 13.5 | 38.1 | |
| Current Liabilities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Accounts Payable | 6.3 | 5.1 | 2.9 | 2.0 | 1.8 | |
| Short-Term Debt | 0.4 | 0.6 | 1.3 | 2.0 | 4.0 | |
| Other Current Liabilities | 4.2 | 6.1 | 4.5 | 2.7 | 2.8 | |
| Current Liabilities | 14.5 | 16.2 | 11.2 | 12.2 | 14.4 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Long-Term Debt | 1.1 | 16.0 | 1.0 | 3.7 | 5.5 | |
| Capital Leases | 1.1 | 2.2 | 1.7 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 51.5 | 51.5 | |
| Total Liabilities | 28.3 | 43.2 | 27.2 | 84.8 | 86.6 | |
| Total Common Equity | TTM | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -278.3 | -309.9 | -248.9 | -166.1 | -143.1 | |
| Comprehensive Income | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 44.1 | 33.0 | 68.0 | -71.2 | -48.5 | |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -55.6 | -52.7 | -61.0 | -49.1 | -23.0 | -21.4 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | |
| Stock-Based Compensation | 9.8 | 12.0 | 10.6 | 7.6 | 0.3 | 0.2 | |
| Change Working Capital | 1.7 | -10.4 | -0.8 | -3.3 | 2.6 | -8.1 | |
| Change In Accounts Receivable | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Change In Accounts Payable | 0.9 | 0.0 | 3.0 | 0.1 | 1.1 | -2.6 | |
| Change In Inventories | 0.1 | -0.1 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Other Non-cash Items | 6.1 | 1.8 | 0.3 | -1.6 | 0.5 | 2.9 | |
| Cash from Operations | -44.6 | 0.0 | 0.0 | -46.1 | -19.4 | -26.2 | |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.5 | -0.3 | -0.1 | -0.3 | -0.5 | |
| Acquisitions | -46.1 | 0.0 | -0.6 | 0.0 | 0.0 | 0.0 | |
| Investments | -84.9 | -76.3 | -72.6 | -142.0 | -0.2 | -15.6 | |
| Sales of Investment | 147.4 | 49.9 | 86.6 | 152.8 | 13.5 | 43.1 | |
| Other Investing Activities | 52.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 62.4 | 0.0 | 0.0 | 10.7 | 13.0 | 27.0 | |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | -10.8 | 0.0 | 0.0 | -10.8 | -4.0 | 0.0 | |
| Debt Issued | 0.7 | 16.5 | 14.8 | 12.5 | 0.2 | 9.5 | |
| Issuance of Common Stock | 0.3 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -10.7 | 0.0 | 0.0 | 57.1 | 0.0 | 0.0 | |
| Cash from Financing | -10.5 | 0.0 | 0.0 | 46.2 | -4.0 | 10.0 | |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -44.7 | -49.5 | -50.8 | -46.2 | -19.7 | -26.7 | |
| Real Free Cash Flow | -54.5 | -61.4 | -61.5 | -53.8 | -20.0 | -26.9 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
